Taiwan: The Clinical Trials Gateway to China?
Taiwan sits, along with its smaller counterparts, Singapore and Hong Kong, as one of the gateway countries to running a clinical trial in China. Although Hong Kong’s regulatory ties are more f […]
了解更多
Taiwan sits, along with its smaller counterparts, Singapore and Hong Kong, as one of the gateway countries to running a clinical trial in China. Although Hong Kong’s regulatory ties are more f […]
了解更多
Generally, the unit of randomization in a randomized clinical trial (RCT) is the individual participant (the patient). Occasionally, the unit of randomization can be a cluster, such as hospitals, schools, villages, etc. When randomizing large groups, the concept of cluster randomized trials (CRTs) has become increasingly common. Patient clusters are allocated to the intervention arms […]
了解更多
On the heels of our recent post on our presence at this week’s DIA Japan 2015, BBK welcomes Philip Gregory, the General Manager of 乔治临床( George Clinical ) – CRO China as our guest contri […]
了解更多
乔治临床( George Clinical ) East Asia is headquartered in Hong Kong. From this location, we oversee our on the ground operations in Hong Kong, Taiwan and Malaysia; whilst enabling coverage of othe […]
了解更多
In order to meet the growing needs of our customers, 乔治临床( George Clinical ) has expanded its geographical footprint within Asia. In 2012 we saw the opening of a second 乔治临床( George Clinical ) […]
了解更多
